StockData
Viatris Inc logo

Viatris Inc (VTRS) stock

VTRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/309% below fair value
$20.45−0.29 (-1.40%)

Close on Nov 17, 2026Market cap $23.49BP/E –Yield 2.35%

Viatris cash

Cash and short-term investments held at the end of each period.

Viatris's cash was $886.50M at Jun 30, 2026. For fiscal 2025 it was $1.36B, up 76.1% from the year before. The highest annual figure on record is $1.36B in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.36B+76.1%
FY2024Dec 31, 2024$774.10M-24.8%
FY2023Dec 31, 2023$1.03B-20.7%
FY2022Dec 31, 2022$1.30B+74.3%
FY2021Dec 31, 2021$744.40M-16.3%
FY2020Dec 31, 2020$889.10M+81.0%
FY2019Dec 31, 2019$491.10M+26.1%
FY2018Dec 31, 2018$389.30M+5.2%
FY2017Dec 31, 2017$369.90M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$886.50M+56.5%
Q1 FY2026Mar 31, 2026$1.80B+139.0%
Q4 FY2025Dec 31, 2025$1.36B+76.1%
Q3 FY2025Sep 30, 2025$975.30M-48.1%
Q2 FY2025Jun 30, 2025$566.40M-38.2%
Q1 FY2025Mar 31, 2025$755.00M-25.6%
Q4 FY2024Dec 31, 2024$774.10M-24.8%
Q3 FY2024Sep 30, 2024$1.88B+43.5%
Q2 FY2024Jun 30, 2024$917.20M+45.8%
Q1 FY2024Mar 31, 2024$1.01B+100.3%
Q4 FY2023Dec 31, 2023$1.03B-20.7%
Q3 FY2023Sep 30, 2023$1.31B+102.5%
Q2 FY2023Jun 30, 2023$629.20M-5.3%
Q1 FY2023Mar 31, 2023$506.60M-32.7%
Q4 FY2022Dec 31, 2022$1.30B+74.3%
Q3 FY2022Sep 30, 2022$646.70M-14.5%
Q2 FY2022Jun 30, 2022$664.70M-1.4%
Q1 FY2022Mar 31, 2022$752.40M-6.8%
Q4 FY2021Dec 31, 2021$744.40M-16.3%
Q3 FY2021Sep 30, 2021$756.60M+13.9%
Q2 FY2021Jun 30, 2021$673.90M+108.3%
Q1 FY2021Mar 31, 2021$806.90M+41.0%
Q4 FY2020Dec 31, 2020$889.10M+81.0%
Q3 FY2020Sep 30, 2020$664.50M–
Q2 FY2020Jun 30, 2020$323.60M–
Q1 FY2020Mar 31, 2020$572.40M–
Q4 FY2019Dec 31, 2019$491.10M+26.1%
Q3 FY2019Sep 29, 2019$0-100.0%
Q2 FY2019Jun 30, 2019$0–
Q1 FY2019Mar 31, 2019$0–
Q4 FY2018Dec 31, 2018$389.30M–
Q4 FY2017Dec 31, 2017$369.90M–

More Viatris figures

See a number that looks wrong?